Ligand Pharmaceuticals, Inc. ( LGNDZ) - Key Metrics
LGNDZ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.17 | $2.42 | $1.20 | $1.20 |
| 2026Q1 | $2.60 | -$0.67 | $2.45 | $2.44 |
| 2025Q4 | $3.02 | $2.27 | $2.32 | $2.32 |
| 2025Q3 | $5.96 | $6.06 | $0.68 | $0.68 |
| 2025Q2 | $2.46 | $0.25 | $0.82 | $0.81 |
LGNDZ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.00 |
| 2026Q1 | 0% | 0.00 |
| 2025Q4 | 0% | 0.00 |
| 2025Q3 | 0% | 0.00 |
| 2025Q2 | 0% | 0.00 |
LGNDZ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 66435.17% | 0% |
| 2026Q1 | 161417.80% | 0% |
| 2025Q4 | 33194.04% | 0% |
| 2025Q3 | 9696.91% | 0% |
| 2025Q2 | 25199.53% | 0% |
LGNDZ
Price: $0
52 week price:
Payout Ratio Range:
Exchange: PNK
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 38078